nodes	percent_of_prediction	percent_of_DWPC	metapath
Glyburide—ABCC9—dilated cardiomyopathy	0.527	1	CbGaD
Glyburide—SLC15A1—Lisinopril—dilated cardiomyopathy	0.0847	0.25	CbGbCtD
Glyburide—SLCO1A2—Spironolactone—dilated cardiomyopathy	0.0677	0.2	CbGbCtD
Glyburide—ABCC2—Spironolactone—dilated cardiomyopathy	0.0561	0.166	CbGbCtD
Glyburide—ABCC2—Furosemide—dilated cardiomyopathy	0.0384	0.113	CbGbCtD
Glyburide—SLC22A6—Furosemide—dilated cardiomyopathy	0.0281	0.083	CbGbCtD
Glyburide—ALB—Furosemide—dilated cardiomyopathy	0.0239	0.0707	CbGbCtD
Glyburide—ABCB1—Lisinopril—dilated cardiomyopathy	0.0208	0.0615	CbGbCtD
Glyburide—ABCB1—Spironolactone—dilated cardiomyopathy	0.0183	0.0541	CbGbCtD
Glyburide—Central nervous system disorder—Furosemide—dilated cardiomyopathy	0.00435	0.0722	CcSEcCtD
Glyburide—CYP2C9—cardial valve—dilated cardiomyopathy	0.00396	0.293	CbGeAlD
Glyburide—Drug eruption—Spironolactone—dilated cardiomyopathy	0.00261	0.0433	CcSEcCtD
Glyburide—Vasculitis—Spironolactone—dilated cardiomyopathy	0.00164	0.0273	CcSEcCtD
Glyburide—KCNJ5—heart—dilated cardiomyopathy	0.00162	0.12	CbGeAlD
Glyburide—Eruption—Furosemide—dilated cardiomyopathy	0.00142	0.0235	CcSEcCtD
Glyburide—Drug eruption—Furosemide—dilated cardiomyopathy	0.00142	0.0235	CcSEcCtD
Glyburide—KCNJ5—cardiac atrium—dilated cardiomyopathy	0.00139	0.103	CbGeAlD
Glyburide—Renal failure acute—Spironolactone—dilated cardiomyopathy	0.00126	0.0209	CcSEcCtD
Glyburide—ABCC9—heart—dilated cardiomyopathy	0.00123	0.0911	CbGeAlD
Glyburide—Blindness—Lisinopril—dilated cardiomyopathy	0.00118	0.0196	CcSEcCtD
Glyburide—Cholestasis—Furosemide—dilated cardiomyopathy	0.00115	0.0191	CcSEcCtD
Glyburide—Inappropriate antidiuretic hormone secretion—Lisinopril—dilated cardiomyopathy	0.00113	0.0187	CcSEcCtD
Glyburide—Eosinophilia—Spironolactone—dilated cardiomyopathy	0.000997	0.0165	CcSEcCtD
Glyburide—Jaundice cholestatic—Furosemide—dilated cardiomyopathy	0.000994	0.0165	CcSEcCtD
Glyburide—Heartburn—Lisinopril—dilated cardiomyopathy	0.000952	0.0158	CcSEcCtD
Glyburide—CPT1A—heart—dilated cardiomyopathy	0.000896	0.0663	CbGeAlD
Glyburide—Vasculitis—Furosemide—dilated cardiomyopathy	0.000895	0.0148	CcSEcCtD
Glyburide—Agranulocytosis—Spironolactone—dilated cardiomyopathy	0.000838	0.0139	CcSEcCtD
Glyburide—ABCA1—heart—dilated cardiomyopathy	0.000834	0.0617	CbGeAlD
Glyburide—Aplastic anaemia—Furosemide—dilated cardiomyopathy	0.00082	0.0136	CcSEcCtD
Glyburide—Jaundice cholestatic—Lisinopril—dilated cardiomyopathy	0.000746	0.0124	CcSEcCtD
Glyburide—Alopecia—Spironolactone—dilated cardiomyopathy	0.000712	0.0118	CcSEcCtD
Glyburide—Deafness—Furosemide—dilated cardiomyopathy	0.000709	0.0118	CcSEcCtD
Glyburide—Vascular purpura—Furosemide—dilated cardiomyopathy	0.000709	0.0118	CcSEcCtD
Glyburide—Haemolytic anaemia—Furosemide—dilated cardiomyopathy	0.000702	0.0116	CcSEcCtD
Glyburide—Vasculitis—Lisinopril—dilated cardiomyopathy	0.000671	0.0111	CcSEcCtD
Glyburide—Dermatitis bullous—Furosemide—dilated cardiomyopathy	0.000663	0.011	CcSEcCtD
Glyburide—Purpura—Furosemide—dilated cardiomyopathy	0.000658	0.0109	CcSEcCtD
Glyburide—Hyponatraemia—Furosemide—dilated cardiomyopathy	0.000636	0.0106	CcSEcCtD
Glyburide—Leukopenia—Spironolactone—dilated cardiomyopathy	0.000628	0.0104	CcSEcCtD
Glyburide—Confusional state—Spironolactone—dilated cardiomyopathy	0.000577	0.00957	CcSEcCtD
Glyburide—Thrombocytopenia—Spironolactone—dilated cardiomyopathy	0.000561	0.0093	CcSEcCtD
Glyburide—Abdominal distension—Furosemide—dilated cardiomyopathy	0.000552	0.00915	CcSEcCtD
Glyburide—Hepatic function abnormal—Lisinopril—dilated cardiomyopathy	0.000544	0.00902	CcSEcCtD
Glyburide—Eosinophilia—Furosemide—dilated cardiomyopathy	0.000542	0.00899	CcSEcCtD
Glyburide—Pancreatitis—Furosemide—dilated cardiomyopathy	0.000537	0.00891	CcSEcCtD
Glyburide—KCNJ11—heart—dilated cardiomyopathy	0.000532	0.0394	CbGeAlD
Glyburide—Hepatic failure—Lisinopril—dilated cardiomyopathy	0.000529	0.00878	CcSEcCtD
Glyburide—Haemolytic anaemia—Lisinopril—dilated cardiomyopathy	0.000527	0.00874	CcSEcCtD
Glyburide—Renal failure acute—Lisinopril—dilated cardiomyopathy	0.000515	0.00854	CcSEcCtD
Glyburide—Photosensitivity reaction—Furosemide—dilated cardiomyopathy	0.0005	0.00829	CcSEcCtD
Glyburide—Renal impairment—Lisinopril—dilated cardiomyopathy	0.0005	0.00829	CcSEcCtD
Glyburide—Gastrointestinal disorder—Spironolactone—dilated cardiomyopathy	0.000494	0.0082	CcSEcCtD
Glyburide—ABCC8—heart—dilated cardiomyopathy	0.00049	0.0363	CbGeAlD
Glyburide—Arthritis—Lisinopril—dilated cardiomyopathy	0.000489	0.00811	CcSEcCtD
Glyburide—Hypoglycaemia—Lisinopril—dilated cardiomyopathy	0.000487	0.00808	CcSEcCtD
Glyburide—Hyponatraemia—Lisinopril—dilated cardiomyopathy	0.000478	0.00792	CcSEcCtD
Glyburide—Diplopia—Lisinopril—dilated cardiomyopathy	0.000476	0.00789	CcSEcCtD
Glyburide—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.000472	0.00783	CcSEcCtD
Glyburide—Agranulocytosis—Furosemide—dilated cardiomyopathy	0.000456	0.00756	CcSEcCtD
Glyburide—Urticaria—Spironolactone—dilated cardiomyopathy	0.000455	0.00754	CcSEcCtD
Glyburide—Visual impairment—Furosemide—dilated cardiomyopathy	0.000423	0.00701	CcSEcCtD
Glyburide—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.000422	0.007	CcSEcCtD
Glyburide—ABCC1—myocardium—dilated cardiomyopathy	0.000415	0.0307	CbGeAlD
Glyburide—Eye disorder—Furosemide—dilated cardiomyopathy	0.00041	0.0068	CcSEcCtD
Glyburide—Eosinophilia—Lisinopril—dilated cardiomyopathy	0.000407	0.00675	CcSEcCtD
Glyburide—Pruritus—Spironolactone—dilated cardiomyopathy	0.000405	0.00672	CcSEcCtD
Glyburide—Pancreatitis—Lisinopril—dilated cardiomyopathy	0.000403	0.00668	CcSEcCtD
Glyburide—Sweating increased—Lisinopril—dilated cardiomyopathy	0.0004	0.00664	CcSEcCtD
Glyburide—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.000392	0.0065	CcSEcCtD
Glyburide—Pancytopenia—Lisinopril—dilated cardiomyopathy	0.00039	0.00647	CcSEcCtD
Glyburide—SLCO2B1—heart—dilated cardiomyopathy	0.000384	0.0284	CbGeAlD
Glyburide—Erythema—Furosemide—dilated cardiomyopathy	0.000382	0.00633	CcSEcCtD
Glyburide—Malnutrition—Furosemide—dilated cardiomyopathy	0.000382	0.00633	CcSEcCtD
Glyburide—Photosensitivity reaction—Lisinopril—dilated cardiomyopathy	0.000375	0.00622	CcSEcCtD
Glyburide—Vomiting—Spironolactone—dilated cardiomyopathy	0.000364	0.00604	CcSEcCtD
Glyburide—Rash—Spironolactone—dilated cardiomyopathy	0.000361	0.00599	CcSEcCtD
Glyburide—Dermatitis—Spironolactone—dilated cardiomyopathy	0.000361	0.00598	CcSEcCtD
Glyburide—Vision blurred—Furosemide—dilated cardiomyopathy	0.00036	0.00597	CcSEcCtD
Glyburide—Headache—Spironolactone—dilated cardiomyopathy	0.000359	0.00595	CcSEcCtD
Glyburide—Jaundice—Lisinopril—dilated cardiomyopathy	0.000357	0.00592	CcSEcCtD
Glyburide—Anaemia—Furosemide—dilated cardiomyopathy	0.000353	0.00585	CcSEcCtD
Glyburide—ALB—heart—dilated cardiomyopathy	0.000351	0.026	CbGeAlD
Glyburide—Agranulocytosis—Lisinopril—dilated cardiomyopathy	0.000342	0.00567	CcSEcCtD
Glyburide—Leukopenia—Furosemide—dilated cardiomyopathy	0.000342	0.00567	CcSEcCtD
Glyburide—Nausea—Spironolactone—dilated cardiomyopathy	0.00034	0.00564	CcSEcCtD
Glyburide—Hepatitis—Lisinopril—dilated cardiomyopathy	0.000329	0.00546	CcSEcCtD
Glyburide—Confusional state—Furosemide—dilated cardiomyopathy	0.000314	0.00521	CcSEcCtD
Glyburide—Shock—Furosemide—dilated cardiomyopathy	0.000307	0.00508	CcSEcCtD
Glyburide—Nervous system disorder—Furosemide—dilated cardiomyopathy	0.000306	0.00507	CcSEcCtD
Glyburide—Thrombocytopenia—Furosemide—dilated cardiomyopathy	0.000305	0.00506	CcSEcCtD
Glyburide—Hyperhidrosis—Furosemide—dilated cardiomyopathy	0.000301	0.00499	CcSEcCtD
Glyburide—Anorexia—Furosemide—dilated cardiomyopathy	0.000297	0.00492	CcSEcCtD
Glyburide—SLC15A2—heart—dilated cardiomyopathy	0.000293	0.0217	CbGeAlD
Glyburide—Hypotension—Furosemide—dilated cardiomyopathy	0.000291	0.00483	CcSEcCtD
Glyburide—Alopecia—Lisinopril—dilated cardiomyopathy	0.000291	0.00482	CcSEcCtD
Glyburide—ABCC1—heart—dilated cardiomyopathy	0.00029	0.0214	CbGeAlD
Glyburide—Malnutrition—Lisinopril—dilated cardiomyopathy	0.000286	0.00475	CcSEcCtD
Glyburide—Erythema—Lisinopril—dilated cardiomyopathy	0.000286	0.00475	CcSEcCtD
Glyburide—Paraesthesia—Furosemide—dilated cardiomyopathy	0.00028	0.00464	CcSEcCtD
Glyburide—Decreased appetite—Furosemide—dilated cardiomyopathy	0.000271	0.00449	CcSEcCtD
Glyburide—Vision blurred—Lisinopril—dilated cardiomyopathy	0.00027	0.00448	CcSEcCtD
Glyburide—Gastrointestinal disorder—Furosemide—dilated cardiomyopathy	0.000269	0.00446	CcSEcCtD
Glyburide—Tremor—Lisinopril—dilated cardiomyopathy	0.000268	0.00445	CcSEcCtD
Glyburide—Anaemia—Lisinopril—dilated cardiomyopathy	0.000265	0.00439	CcSEcCtD
Glyburide—Angioedema—Lisinopril—dilated cardiomyopathy	0.000262	0.00434	CcSEcCtD
Glyburide—Feeling abnormal—Furosemide—dilated cardiomyopathy	0.000257	0.00426	CcSEcCtD
Glyburide—Leukopenia—Lisinopril—dilated cardiomyopathy	0.000256	0.00425	CcSEcCtD
Glyburide—Gastrointestinal pain—Furosemide—dilated cardiomyopathy	0.000255	0.00422	CcSEcCtD
Glyburide—ABCC1—cardiac atrium—dilated cardiomyopathy	0.000248	0.0183	CbGeAlD
Glyburide—Urticaria—Furosemide—dilated cardiomyopathy	0.000248	0.0041	CcSEcCtD
Glyburide—Abdominal pain—Furosemide—dilated cardiomyopathy	0.000246	0.00408	CcSEcCtD
Glyburide—Arthralgia—Lisinopril—dilated cardiomyopathy	0.000244	0.00404	CcSEcCtD
Glyburide—Myalgia—Lisinopril—dilated cardiomyopathy	0.000244	0.00404	CcSEcCtD
Glyburide—ABCG2—heart—dilated cardiomyopathy	0.00024	0.0177	CbGeAlD
Glyburide—Confusional state—Lisinopril—dilated cardiomyopathy	0.000236	0.00391	CcSEcCtD
Glyburide—Oedema—Lisinopril—dilated cardiomyopathy	0.000234	0.00388	CcSEcCtD
Glyburide—Shock—Lisinopril—dilated cardiomyopathy	0.00023	0.00381	CcSEcCtD
Glyburide—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.00023	0.00381	CcSEcCtD
Glyburide—Thrombocytopenia—Lisinopril—dilated cardiomyopathy	0.000229	0.0038	CcSEcCtD
Glyburide—Hyperhidrosis—Lisinopril—dilated cardiomyopathy	0.000226	0.00375	CcSEcCtD
Glyburide—Asthenia—Furosemide—dilated cardiomyopathy	0.000224	0.00371	CcSEcCtD
Glyburide—Anorexia—Lisinopril—dilated cardiomyopathy	0.000223	0.00369	CcSEcCtD
Glyburide—Pruritus—Furosemide—dilated cardiomyopathy	0.00022	0.00366	CcSEcCtD
Glyburide—CYP2C9—heart—dilated cardiomyopathy	0.000219	0.0162	CbGeAlD
Glyburide—Hypotension—Lisinopril—dilated cardiomyopathy	0.000218	0.00362	CcSEcCtD
Glyburide—Diarrhoea—Furosemide—dilated cardiomyopathy	0.000213	0.00353	CcSEcCtD
Glyburide—Musculoskeletal discomfort—Lisinopril—dilated cardiomyopathy	0.000213	0.00353	CcSEcCtD
Glyburide—Paraesthesia—Lisinopril—dilated cardiomyopathy	0.00021	0.00348	CcSEcCtD
Glyburide—Dyspnoea—Lisinopril—dilated cardiomyopathy	0.000208	0.00346	CcSEcCtD
Glyburide—Dyspepsia—Lisinopril—dilated cardiomyopathy	0.000206	0.00341	CcSEcCtD
Glyburide—Decreased appetite—Lisinopril—dilated cardiomyopathy	0.000203	0.00337	CcSEcCtD
Glyburide—Gastrointestinal disorder—Lisinopril—dilated cardiomyopathy	0.000202	0.00335	CcSEcCtD
Glyburide—Vomiting—Furosemide—dilated cardiomyopathy	0.000198	0.00328	CcSEcCtD
Glyburide—Rash—Furosemide—dilated cardiomyopathy	0.000196	0.00326	CcSEcCtD
Glyburide—Dermatitis—Furosemide—dilated cardiomyopathy	0.000196	0.00325	CcSEcCtD
Glyburide—Headache—Furosemide—dilated cardiomyopathy	0.000195	0.00324	CcSEcCtD
Glyburide—Feeling abnormal—Lisinopril—dilated cardiomyopathy	0.000193	0.00319	CcSEcCtD
Glyburide—Gastrointestinal pain—Lisinopril—dilated cardiomyopathy	0.000191	0.00317	CcSEcCtD
Glyburide—Urticaria—Lisinopril—dilated cardiomyopathy	0.000186	0.00308	CcSEcCtD
Glyburide—Nausea—Furosemide—dilated cardiomyopathy	0.000185	0.00307	CcSEcCtD
Glyburide—Abdominal pain—Lisinopril—dilated cardiomyopathy	0.000185	0.00306	CcSEcCtD
Glyburide—Hypersensitivity—Lisinopril—dilated cardiomyopathy	0.000172	0.00286	CcSEcCtD
Glyburide—Asthenia—Lisinopril—dilated cardiomyopathy	0.000168	0.00278	CcSEcCtD
Glyburide—Pruritus—Lisinopril—dilated cardiomyopathy	0.000165	0.00274	CcSEcCtD
Glyburide—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.00016	0.00265	CcSEcCtD
Glyburide—Vomiting—Lisinopril—dilated cardiomyopathy	0.000149	0.00246	CcSEcCtD
Glyburide—Rash—Lisinopril—dilated cardiomyopathy	0.000147	0.00244	CcSEcCtD
Glyburide—Dermatitis—Lisinopril—dilated cardiomyopathy	0.000147	0.00244	CcSEcCtD
Glyburide—Headache—Lisinopril—dilated cardiomyopathy	0.000146	0.00243	CcSEcCtD
Glyburide—Nausea—Lisinopril—dilated cardiomyopathy	0.000139	0.0023	CcSEcCtD
Glyburide—ABCB1—heart—dilated cardiomyopathy	0.000118	0.00875	CbGeAlD
Glyburide—ABCA1—Folate Metabolism—TNF—dilated cardiomyopathy	0.000113	0.00185	CbGpPWpGaD
Glyburide—ABCA1—Fatty acid, triacylglycerol, and ketone body metabolism—AGT—dilated cardiomyopathy	0.000112	0.00183	CbGpPWpGaD
Glyburide—CPT1A—Fatty acid, triacylglycerol, and ketone body metabolism—AGT—dilated cardiomyopathy	0.000112	0.00183	CbGpPWpGaD
Glyburide—ALB—Platelet degranulation—VCL—dilated cardiomyopathy	0.00011	0.0018	CbGpPWpGaD
Glyburide—CPT1A—Circadian rythm related genes—FAS—dilated cardiomyopathy	0.000109	0.00178	CbGpPWpGaD
Glyburide—SLC22A6—SLC-mediated transmembrane transport—SLC22A5—dilated cardiomyopathy	0.000109	0.00178	CbGpPWpGaD
Glyburide—ABCB11—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.000107	0.00175	CbGpPWpGaD
Glyburide—ALB—Response to elevated platelet cytosolic Ca2+—VCL—dilated cardiomyopathy	0.000105	0.00172	CbGpPWpGaD
Glyburide—ABCC3—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.000103	0.00168	CbGpPWpGaD
Glyburide—ABCB11—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.000101	0.00165	CbGpPWpGaD
Glyburide—KCNJ5—Neuronal System—RAF1—dilated cardiomyopathy	9.95e-05	0.00163	CbGpPWpGaD
Glyburide—SLCO2B1—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	9.88e-05	0.00162	CbGpPWpGaD
Glyburide—ABCA1—Metabolism—ANKRD1—dilated cardiomyopathy	9.77e-05	0.0016	CbGpPWpGaD
Glyburide—CPT1A—Metabolism—ANKRD1—dilated cardiomyopathy	9.77e-05	0.0016	CbGpPWpGaD
Glyburide—ABCC3—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	9.66e-05	0.00158	CbGpPWpGaD
Glyburide—SLCO2B1—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	9.61e-05	0.00157	CbGpPWpGaD
Glyburide—SLCO2B1—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	9.61e-05	0.00157	CbGpPWpGaD
Glyburide—ABCA1—Metabolism—TAZ—dilated cardiomyopathy	9.19e-05	0.0015	CbGpPWpGaD
Glyburide—CPT1A—Metabolism—TAZ—dilated cardiomyopathy	9.19e-05	0.0015	CbGpPWpGaD
Glyburide—ABCC8—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	9.18e-05	0.0015	CbGpPWpGaD
Glyburide—ABCA1—Selenium Micronutrient Network—TNF—dilated cardiomyopathy	8.96e-05	0.00147	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	8.94e-05	0.00146	CbGpPWpGaD
Glyburide—ABCC8—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	8.93e-05	0.00146	CbGpPWpGaD
Glyburide—ABCC8—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	8.93e-05	0.00146	CbGpPWpGaD
Glyburide—SLCO2B1—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	8.93e-05	0.00146	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	8.41e-05	0.00138	CbGpPWpGaD
Glyburide—CPT1A—Metabolism—SDHA—dilated cardiomyopathy	8.31e-05	0.00136	CbGpPWpGaD
Glyburide—ABCA1—Metabolism—SDHA—dilated cardiomyopathy	8.31e-05	0.00136	CbGpPWpGaD
Glyburide—ABCC8—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	8.3e-05	0.00136	CbGpPWpGaD
Glyburide—SLC15A2—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	8.27e-05	0.00135	CbGpPWpGaD
Glyburide—SLC22A7—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	8.12e-05	0.00133	CbGpPWpGaD
Glyburide—ALB—Binding and Uptake of Ligands by Scavenger Receptors—CD36—dilated cardiomyopathy	8.06e-05	0.00132	CbGpPWpGaD
Glyburide—ABCC1—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	8.05e-05	0.00132	CbGpPWpGaD
Glyburide—SLC15A2—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	8.04e-05	0.00132	CbGpPWpGaD
Glyburide—SLC15A2—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	8.04e-05	0.00132	CbGpPWpGaD
Glyburide—SLC22A7—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	7.9e-05	0.00129	CbGpPWpGaD
Glyburide—SLC22A7—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	7.9e-05	0.00129	CbGpPWpGaD
Glyburide—ABCC9—Neuronal System—RAF1—dilated cardiomyopathy	7.87e-05	0.00129	CbGpPWpGaD
Glyburide—SLC15A1—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	7.67e-05	0.00126	CbGpPWpGaD
Glyburide—ABCC1—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	7.57e-05	0.00124	CbGpPWpGaD
Glyburide—SLC15A2—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	7.48e-05	0.00122	CbGpPWpGaD
Glyburide—SLC15A1—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	7.46e-05	0.00122	CbGpPWpGaD
Glyburide—SLC15A1—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	7.46e-05	0.00122	CbGpPWpGaD
Glyburide—SLC22A7—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	7.34e-05	0.0012	CbGpPWpGaD
Glyburide—ALB—Vitamin B12 Metabolism—SOD2—dilated cardiomyopathy	7.29e-05	0.00119	CbGpPWpGaD
Glyburide—ABCC3—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	6.96e-05	0.00114	CbGpPWpGaD
Glyburide—SLC15A1—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	6.94e-05	0.00114	CbGpPWpGaD
Glyburide—ABCC3—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	6.77e-05	0.00111	CbGpPWpGaD
Glyburide—ABCC3—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	6.77e-05	0.00111	CbGpPWpGaD
Glyburide—ALB—Platelet activation, signaling and aggregation—TTN—dilated cardiomyopathy	6.64e-05	0.00109	CbGpPWpGaD
Glyburide—KCNJ1—Neuronal System—RAF1—dilated cardiomyopathy	6.59e-05	0.00108	CbGpPWpGaD
Glyburide—ABCB1—Integrated Pancreatic Cancer Pathway—PLN—dilated cardiomyopathy	6.36e-05	0.00104	CbGpPWpGaD
Glyburide—CYP2C19—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	6.34e-05	0.00104	CbGpPWpGaD
Glyburide—ABCC3—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	6.29e-05	0.00103	CbGpPWpGaD
Glyburide—SLCO1A2—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	6.06e-05	0.000992	CbGpPWpGaD
Glyburide—ABCC8—Metabolism—ANKRD1—dilated cardiomyopathy	6.04e-05	0.000988	CbGpPWpGaD
Glyburide—ALB—Folate Metabolism—SOD2—dilated cardiomyopathy	5.93e-05	0.00097	CbGpPWpGaD
Glyburide—SLCO1A2—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	5.9e-05	0.000965	CbGpPWpGaD
Glyburide—SLCO1A2—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	5.9e-05	0.000965	CbGpPWpGaD
Glyburide—KCNJ11—Metabolism—ANKRD1—dilated cardiomyopathy	5.85e-05	0.000958	CbGpPWpGaD
Glyburide—CFTR—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	5.85e-05	0.000958	CbGpPWpGaD
Glyburide—CYP2C9—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	5.78e-05	0.000946	CbGpPWpGaD
Glyburide—ALB—Platelet activation, signaling and aggregation—ACTN2—dilated cardiomyopathy	5.75e-05	0.000942	CbGpPWpGaD
Glyburide—SLC22A6—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	5.7e-05	0.000932	CbGpPWpGaD
Glyburide—ABCC8—Metabolism—TAZ—dilated cardiomyopathy	5.68e-05	0.000929	CbGpPWpGaD
Glyburide—CPT1A—SIDS Susceptibility Pathways—TNF—dilated cardiomyopathy	5.67e-05	0.000928	CbGpPWpGaD
Glyburide—ALB—SLC-mediated transmembrane transport—SLC22A5—dilated cardiomyopathy	5.67e-05	0.000928	CbGpPWpGaD
Glyburide—ALB—Folate Metabolism—GPX1—dilated cardiomyopathy	5.66e-05	0.000926	CbGpPWpGaD
Glyburide—SLC22A6—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	5.54e-05	0.000907	CbGpPWpGaD
Glyburide—SLC22A6—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	5.54e-05	0.000907	CbGpPWpGaD
Glyburide—ABCC2—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	5.52e-05	0.000903	CbGpPWpGaD
Glyburide—KCNJ11—Metabolism—TAZ—dilated cardiomyopathy	5.5e-05	0.000901	CbGpPWpGaD
Glyburide—SLCO1A2—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	5.48e-05	0.000897	CbGpPWpGaD
Glyburide—ABCC1—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	5.45e-05	0.000892	CbGpPWpGaD
Glyburide—ABCC2—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	5.37e-05	0.000878	CbGpPWpGaD
Glyburide—ABCC2—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	5.37e-05	0.000878	CbGpPWpGaD
Glyburide—ABCB1—Allograft Rejection—AGTR1—dilated cardiomyopathy	5.35e-05	0.000875	CbGpPWpGaD
Glyburide—ABCC1—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	5.3e-05	0.000868	CbGpPWpGaD
Glyburide—ABCC1—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	5.3e-05	0.000868	CbGpPWpGaD
Glyburide—SLC22A6—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	5.15e-05	0.000843	CbGpPWpGaD
Glyburide—ABCC8—Metabolism—SDHA—dilated cardiomyopathy	5.13e-05	0.00084	CbGpPWpGaD
Glyburide—CPT1A—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	5.07e-05	0.000829	CbGpPWpGaD
Glyburide—ABCA1—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	5.07e-05	0.000829	CbGpPWpGaD
Glyburide—ABCC2—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	4.99e-05	0.000817	CbGpPWpGaD
Glyburide—KCNJ11—Metabolism—SDHA—dilated cardiomyopathy	4.98e-05	0.000814	CbGpPWpGaD
Glyburide—CPT1A—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	4.94e-05	0.000808	CbGpPWpGaD
Glyburide—ABCA1—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	4.94e-05	0.000808	CbGpPWpGaD
Glyburide—ABCC1—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	4.93e-05	0.000807	CbGpPWpGaD
Glyburide—ALB—Platelet activation, signaling and aggregation—VCL—dilated cardiomyopathy	4.89e-05	0.000801	CbGpPWpGaD
Glyburide—ABCG2—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	4.8e-05	0.000785	CbGpPWpGaD
Glyburide—ABCB11—Metabolism—ANKRD1—dilated cardiomyopathy	4.77e-05	0.000781	CbGpPWpGaD
Glyburide—ALB—Platelet degranulation—CD36—dilated cardiomyopathy	4.72e-05	0.000773	CbGpPWpGaD
Glyburide—ALB—Selenium Micronutrient Network—SOD2—dilated cardiomyopathy	4.71e-05	0.000771	CbGpPWpGaD
Glyburide—ABCG2—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	4.67e-05	0.000764	CbGpPWpGaD
Glyburide—ABCG2—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	4.67e-05	0.000764	CbGpPWpGaD
Glyburide—ABCC3—Metabolism—ANKRD1—dilated cardiomyopathy	4.57e-05	0.000749	CbGpPWpGaD
Glyburide—ALB—Response to elevated platelet cytosolic Ca2+—CD36—dilated cardiomyopathy	4.5e-05	0.000736	CbGpPWpGaD
Glyburide—ALB—Selenium Micronutrient Network—GPX1—dilated cardiomyopathy	4.49e-05	0.000735	CbGpPWpGaD
Glyburide—ABCB11—Metabolism—TAZ—dilated cardiomyopathy	4.49e-05	0.000734	CbGpPWpGaD
Glyburide—ABCB1—Allograft Rejection—IL10—dilated cardiomyopathy	4.48e-05	0.000733	CbGpPWpGaD
Glyburide—ABCA1—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	4.44e-05	0.000727	CbGpPWpGaD
Glyburide—CPT1A—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	4.44e-05	0.000727	CbGpPWpGaD
Glyburide—ALB—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	4.37e-05	0.000715	CbGpPWpGaD
Glyburide—ABCG2—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	4.34e-05	0.00071	CbGpPWpGaD
Glyburide—ABCC3—Metabolism—TAZ—dilated cardiomyopathy	4.3e-05	0.000704	CbGpPWpGaD
Glyburide—ABCC9—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	4.23e-05	0.000692	CbGpPWpGaD
Glyburide—ABCB1—Allograft Rejection—FASLG—dilated cardiomyopathy	4.17e-05	0.000682	CbGpPWpGaD
Glyburide—ALB—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	4.11e-05	0.000672	CbGpPWpGaD
Glyburide—ABCB11—Metabolism—SDHA—dilated cardiomyopathy	4.06e-05	0.000664	CbGpPWpGaD
Glyburide—ABCB1—Allograft Rejection—FAS—dilated cardiomyopathy	4.02e-05	0.000657	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism—ANKRD1—dilated cardiomyopathy	3.98e-05	0.000652	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	3.92e-05	0.000642	CbGpPWpGaD
Glyburide—ABCC3—Metabolism—SDHA—dilated cardiomyopathy	3.89e-05	0.000637	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism—TAZ—dilated cardiomyopathy	3.75e-05	0.000613	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	3.69e-05	0.000604	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—ANKRD1—dilated cardiomyopathy	3.58e-05	0.000587	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	3.58e-05	0.000585	CbGpPWpGaD
Glyburide—ALB—Hemostasis—TTN—dilated cardiomyopathy	3.42e-05	0.00056	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism—SDHA—dilated cardiomyopathy	3.39e-05	0.000554	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—TAZ—dilated cardiomyopathy	3.37e-05	0.000552	CbGpPWpGaD
Glyburide—ABCC8—Neuronal System—RAF1—dilated cardiomyopathy	3.37e-05	0.000551	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	3.36e-05	0.00055	CbGpPWpGaD
Glyburide—KCNJ11—Neuronal System—RAF1—dilated cardiomyopathy	3.27e-05	0.000535	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—ANKRD1—dilated cardiomyopathy	3.15e-05	0.000516	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—SDHA—dilated cardiomyopathy	3.05e-05	0.000499	CbGpPWpGaD
Glyburide—ALB—Hemostasis—ACTN2—dilated cardiomyopathy	2.97e-05	0.000485	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—TAZ—dilated cardiomyopathy	2.97e-05	0.000485	CbGpPWpGaD
Glyburide—ALB—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	2.96e-05	0.000485	CbGpPWpGaD
Glyburide—ALB—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	2.88e-05	0.000471	CbGpPWpGaD
Glyburide—ALB—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	2.88e-05	0.000471	CbGpPWpGaD
Glyburide—ALB—Vitamin B12 Metabolism—TNF—dilated cardiomyopathy	2.76e-05	0.000452	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—SDHA—dilated cardiomyopathy	2.68e-05	0.000439	CbGpPWpGaD
Glyburide—ALB—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	2.68e-05	0.000438	CbGpPWpGaD
Glyburide—ABCB1—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	2.59e-05	0.000425	CbGpPWpGaD
Glyburide—ABCB1—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	2.52e-05	0.000413	CbGpPWpGaD
Glyburide—ABCB1—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	2.52e-05	0.000413	CbGpPWpGaD
Glyburide—ALB—Hemostasis—VCL—dilated cardiomyopathy	2.52e-05	0.000413	CbGpPWpGaD
Glyburide—ABCB11—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	2.47e-05	0.000405	CbGpPWpGaD
Glyburide—ABCB11—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	2.41e-05	0.000394	CbGpPWpGaD
Glyburide—ABCC3—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	2.37e-05	0.000388	CbGpPWpGaD
Glyburide—ABCB1—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	2.35e-05	0.000384	CbGpPWpGaD
Glyburide—ABCC3—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	2.31e-05	0.000378	CbGpPWpGaD
Glyburide—CPT1A—Metabolism—GPX1—dilated cardiomyopathy	2.26e-05	0.000369	CbGpPWpGaD
Glyburide—ABCA1—Metabolism—GPX1—dilated cardiomyopathy	2.26e-05	0.000369	CbGpPWpGaD
Glyburide—ALB—Folate Metabolism—TNF—dilated cardiomyopathy	2.25e-05	0.000368	CbGpPWpGaD
Glyburide—CPT1A—Metabolism—CD36—dilated cardiomyopathy	2.2e-05	0.00036	CbGpPWpGaD
Glyburide—ABCA1—Metabolism—CD36—dilated cardiomyopathy	2.2e-05	0.00036	CbGpPWpGaD
Glyburide—ABCB11—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	2.17e-05	0.000355	CbGpPWpGaD
Glyburide—ALB—Platelet activation, signaling and aggregation—CD36—dilated cardiomyopathy	2.09e-05	0.000343	CbGpPWpGaD
Glyburide—ABCC3—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	2.08e-05	0.00034	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	2.07e-05	0.000338	CbGpPWpGaD
Glyburide—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—dilated cardiomyopathy	2.06e-05	0.000336	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	2.01e-05	0.000329	CbGpPWpGaD
Glyburide—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—dilated cardiomyopathy	1.98e-05	0.000324	CbGpPWpGaD
Glyburide—ABCA1—Metabolism—AGT—dilated cardiomyopathy	1.98e-05	0.000324	CbGpPWpGaD
Glyburide—CPT1A—Metabolism—AGT—dilated cardiomyopathy	1.98e-05	0.000324	CbGpPWpGaD
Glyburide—ALB—Platelet activation, signaling and aggregation—RAC1—dilated cardiomyopathy	1.97e-05	0.000323	CbGpPWpGaD
Glyburide—SLCO2B1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	1.95e-05	0.000319	CbGpPWpGaD
Glyburide—ALB—Metabolism—ANKRD1—dilated cardiomyopathy	1.95e-05	0.000319	CbGpPWpGaD
Glyburide—ABCB1—Integrated Pancreatic Cancer Pathway—RAC1—dilated cardiomyopathy	1.94e-05	0.000318	CbGpPWpGaD
Glyburide—ABCC1—Disease—NPPA—dilated cardiomyopathy	1.86e-05	0.000305	CbGpPWpGaD
Glyburide—ABCC1—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	1.86e-05	0.000304	CbGpPWpGaD
Glyburide—ALB—Metabolism—TAZ—dilated cardiomyopathy	1.83e-05	0.000299	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	1.81e-05	0.000296	CbGpPWpGaD
Glyburide—ABCC8—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	1.81e-05	0.000296	CbGpPWpGaD
Glyburide—ABCC1—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	1.81e-05	0.000296	CbGpPWpGaD
Glyburide—ABCC1—Disease—PSEN2—dilated cardiomyopathy	1.8e-05	0.000295	CbGpPWpGaD
Glyburide—ALB—Selenium Micronutrient Network—TNF—dilated cardiomyopathy	1.79e-05	0.000292	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—ANKRD1—dilated cardiomyopathy	1.75e-05	0.000286	CbGpPWpGaD
Glyburide—ABCB1—Allograft Rejection—TNF—dilated cardiomyopathy	1.71e-05	0.000279	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—ANKRD1—dilated cardiomyopathy	1.71e-05	0.000279	CbGpPWpGaD
Glyburide—ALB—Metabolism—SDHA—dilated cardiomyopathy	1.65e-05	0.000271	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—TAZ—dilated cardiomyopathy	1.64e-05	0.000269	CbGpPWpGaD
Glyburide—SLC15A2—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	1.63e-05	0.000267	CbGpPWpGaD
Glyburide—ABCC1—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	1.63e-05	0.000267	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—TAZ—dilated cardiomyopathy	1.6e-05	0.000262	CbGpPWpGaD
Glyburide—SLC22A7—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	1.6e-05	0.000262	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—ANKRD1—dilated cardiomyopathy	1.59e-05	0.000261	CbGpPWpGaD
Glyburide—SLC15A1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	1.51e-05	0.000248	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—TAZ—dilated cardiomyopathy	1.5e-05	0.000245	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—SDHA—dilated cardiomyopathy	1.49e-05	0.000243	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—SDHA—dilated cardiomyopathy	1.45e-05	0.000237	CbGpPWpGaD
Glyburide—ABCC8—Metabolism—GPX1—dilated cardiomyopathy	1.39e-05	0.000228	CbGpPWpGaD
Glyburide—ABCC3—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	1.37e-05	0.000225	CbGpPWpGaD
Glyburide—ABCC8—Metabolism—CD36—dilated cardiomyopathy	1.36e-05	0.000222	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—SDHA—dilated cardiomyopathy	1.35e-05	0.000222	CbGpPWpGaD
Glyburide—KCNJ11—Metabolism—GPX1—dilated cardiomyopathy	1.35e-05	0.000221	CbGpPWpGaD
Glyburide—KCNJ11—Metabolism—CD36—dilated cardiomyopathy	1.32e-05	0.000215	CbGpPWpGaD
Glyburide—ALB—Platelet activation, signaling and aggregation—RAF1—dilated cardiomyopathy	1.31e-05	0.000214	CbGpPWpGaD
Glyburide—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—dilated cardiomyopathy	1.29e-05	0.000211	CbGpPWpGaD
Glyburide—ALB—Hemostasis—ITGB1—dilated cardiomyopathy	1.27e-05	0.000207	CbGpPWpGaD
Glyburide—ABCC8—Metabolism—AGT—dilated cardiomyopathy	1.22e-05	0.0002	CbGpPWpGaD
Glyburide—SLCO1A2—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	1.2e-05	0.000196	CbGpPWpGaD
Glyburide—KCNJ11—Metabolism—AGT—dilated cardiomyopathy	1.19e-05	0.000194	CbGpPWpGaD
Glyburide—SLC22A6—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	1.12e-05	0.000184	CbGpPWpGaD
Glyburide—ABCB11—Metabolism—GPX1—dilated cardiomyopathy	1.1e-05	0.00018	CbGpPWpGaD
Glyburide—ABCC2—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	1.09e-05	0.000178	CbGpPWpGaD
Glyburide—ALB—Hemostasis—CD36—dilated cardiomyopathy	1.08e-05	0.000177	CbGpPWpGaD
Glyburide—ABCC1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	1.08e-05	0.000176	CbGpPWpGaD
Glyburide—ABCB11—Metabolism—CD36—dilated cardiomyopathy	1.07e-05	0.000176	CbGpPWpGaD
Glyburide—ABCC3—Metabolism—GPX1—dilated cardiomyopathy	1.06e-05	0.000173	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—ANKRD1—dilated cardiomyopathy	1.05e-05	0.000172	CbGpPWpGaD
Glyburide—ABCC3—Metabolism—CD36—dilated cardiomyopathy	1.03e-05	0.000168	CbGpPWpGaD
Glyburide—ALB—Hemostasis—RAC1—dilated cardiomyopathy	1.02e-05	0.000167	CbGpPWpGaD
Glyburide—ALB—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	1.01e-05	0.000165	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—TAZ—dilated cardiomyopathy	9.88e-06	0.000162	CbGpPWpGaD
Glyburide—ALB—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	9.83e-06	0.000161	CbGpPWpGaD
Glyburide—ABCB11—Metabolism—AGT—dilated cardiomyopathy	9.66e-06	0.000158	CbGpPWpGaD
Glyburide—ABCG2—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	9.47e-06	0.000155	CbGpPWpGaD
Glyburide—ABCC3—Metabolism—AGT—dilated cardiomyopathy	9.27e-06	0.000152	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism—GPX1—dilated cardiomyopathy	9.2e-06	0.000151	CbGpPWpGaD
Glyburide—ABCC1—Disease—RAC1—dilated cardiomyopathy	9.07e-06	0.000148	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	9.06e-06	0.000148	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism—CD36—dilated cardiomyopathy	8.96e-06	0.000147	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—SDHA—dilated cardiomyopathy	8.93e-06	0.000146	CbGpPWpGaD
Glyburide—ALB—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	8.85e-06	0.000145	CbGpPWpGaD
Glyburide—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—dilated cardiomyopathy	8.84e-06	0.000145	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	8.82e-06	0.000144	CbGpPWpGaD
Glyburide—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—dilated cardiomyopathy	8.42e-06	0.000138	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—GPX1—dilated cardiomyopathy	8.28e-06	0.000135	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	8.26e-06	0.000135	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism—AGT—dilated cardiomyopathy	8.07e-06	0.000132	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—CD36—dilated cardiomyopathy	8.06e-06	0.000132	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	8.05e-06	0.000132	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	7.95e-06	0.00013	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—GPX1—dilated cardiomyopathy	7.29e-06	0.000119	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—AGT—dilated cardiomyopathy	7.26e-06	0.000119	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	7.24e-06	0.000119	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—CD36—dilated cardiomyopathy	7.1e-06	0.000116	CbGpPWpGaD
Glyburide—ALB—Hemostasis—RAF1—dilated cardiomyopathy	6.75e-06	0.00011	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—AGT—dilated cardiomyopathy	6.39e-06	0.000105	CbGpPWpGaD
Glyburide—ABCC1—Disease—RAF1—dilated cardiomyopathy	6.02e-06	9.85e-05	CbGpPWpGaD
Glyburide—ALB—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	5.84e-06	9.56e-05	CbGpPWpGaD
Glyburide—ABCB1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	5.12e-06	8.38e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—GPX1—dilated cardiomyopathy	4.5e-06	7.36e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—CD36—dilated cardiomyopathy	4.38e-06	7.16e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—EGFR—dilated cardiomyopathy	4.13e-06	6.75e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—GPX1—dilated cardiomyopathy	4.04e-06	6.6e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—AGT—dilated cardiomyopathy	3.94e-06	6.45e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—GPX1—dilated cardiomyopathy	3.94e-06	6.45e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—CD36—dilated cardiomyopathy	3.93e-06	6.43e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—CD36—dilated cardiomyopathy	3.84e-06	6.28e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—GPX1—dilated cardiomyopathy	3.68e-06	6.02e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—CD36—dilated cardiomyopathy	3.58e-06	5.86e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—AGT—dilated cardiomyopathy	3.54e-06	5.79e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—AGT—dilated cardiomyopathy	3.45e-06	5.65e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—AGT—dilated cardiomyopathy	3.23e-06	5.28e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—GPX1—dilated cardiomyopathy	2.43e-06	3.97e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—CD36—dilated cardiomyopathy	2.36e-06	3.87e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—AGT—dilated cardiomyopathy	2.13e-06	3.48e-05	CbGpPWpGaD
